CSL Finance Ltd
₹226.45
▼-0.04%
Open
₹228.95
High
₹229
Low
₹224.95
Volume
12.5K
Price chart
Daily close · downsampled 5-year history
2021-06-21 · ₹114.172026-06-18 · ₹224.15
Instrument details
- MB Code
- MBEQU1240
- Type
- stock
- ISIN
- INE718F01018
- BSE
- 530067
- Industry
- Finance
Latest earnings
Q4FY26 declared
- Quarter
- Mar 2026
- Revenue
- 68.8 Cr
- Net profit
- 19.42 Cr
- EPS
- 8.46
- YoY revenue
- +21.71%
Price returns
Historical performance
- 1 day
- -1.02%
- 1 month
- -0.38%
- 3 months
- -10.63%
- 1 year
- -31.73%
- 3 years
- -17.85%
- 5 years
- +102.54%
Technicals
Indicator consensus
Bullish
4
Neutral
8
Bearish
34
RSI 43.35(Neutral)
Company documents
Annual reports, concalls, presentations
Concall transcripts
34Investor presentations
68Corporate announcements
234Corporate timeline
Price chart events · 1 year
Dividend
2025-09-12
{"amount":3}
News
2026-02-10
{"description":"CSL's shares fell to an 8-year low following the announcement of CEO Paul McKenzie's departure and disappointing earnings results, raising concerns about the company's future leadership and performance.","url":"https://www.msn.com/en-us/money/other/shares-of-australian-biotech-major-csl-plunge-to-8-year-low-after-ceo-departure-weak-earnings/ar-AA1W5IOJ?ocid=BingNewsVerp","sentiment":"Negative","domain":"CNBC on MSN"}
News
2025-08-19
{"description":"CSL, Australia's fourth-largest company, plans to spin off its vaccine division and cut up to 3,000 jobs, leading to a significant drop in shares.","url":"https://www.msn.com/en-us/money/markets/csl-to-axe-up-to-3000-employees-and-spin-off-vaccine-arm-shares-tumble/ar-AA1KO47k?ocid=BingNewsVerp","sentiment":"Negative","domain":"Reuters on MSN"}
News
2025-08-18
{"description":"CSL plans to cut up to 15% of its staff and spin off its Seqirus business in a restructuring effort costing up to $770 million.","url":"https://www.morningstar.com/news/dow-jones/202508188264/csl-to-cut-up-to-15-of-staff-in-770-million-restructure","sentiment":"Negative","domain":"Morningstar"}